Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Develops and discovers small molecule therapeutics.
Year Established: | |
Funding: | |
Address: | Avila Therapeutics, Inc. 100 Beaver Street Waltham, MA 02453 |
Telephone: | 2147483647 |
Mobile: | |
Fax: | 781-891-0069 |
Mail: | info@avilatx.com |
Company URL: | http://www.avilatx.com |
Avila Therapeutics, Inc. is looking for individuals with the skills and talents that will most effectively contribute to our mission. Our success depends upon the talents of people who are committed to help solve some of the most challenging issues within medicine. Come join a world-class team of drug discovery and development professionals in building one of the most promising biotechnology start-ups in the Boston area.
At Avila Therapeutics, you will enjoy a competitive salary, generous stock options, excellent health and dental insurance, flexible spending program for both medical and dependent care, life and disability insurance coverage, 401k plan, and well-deserved vacation time
If you do not see a suitable position today, please check back another time, as we often update our requirements. Or if you know of someone who would be a great candidate, please ask them to submit their resume.
There are currently no openings; please check back at a later date.
Thank you for considering Avila Therapeutics.
Avila Therapeutics is an Equal Opportunity and Affirmative Action employer committed to a culturally diverse workforce.
4/16/10
3/29/10
Avila establishes $3.2M collaboration with Leukemia & Lymphoma Society
3/10/10
Avila Presents at Cowen and Company 30th Annual Healthcare Conference
2/26/10
xConomy: "Avila Aims to Trump Vertex With Drug that Hits Hepatitis C Virus and Won't Let Go"
2/12/2010
Pharmawire: "Avila Therapeutics to Advance Lead Covalent Drug Programs to Clinic this Year"
1/28/10
BIO-IT WORLD.COM: "Avila Therapeutics Targets the Covalent Proteome"
10/5/09
9/25/09
EP Vantage: "Avila covalent drugs looking highly attractive"
9/01/09
Drug Discovery News: "Novartis sponsors Avila Therapeutics' covalent drug candidate"
7/28/09
BioWorld: "Avila Raises $30M, Pulls Down $200M deal with Novartis Fund"
7/27/09
Avila Therapeutics, Inc. Closes $30 Million Series B Financing
7/27/09
Avila Therapeutics Announces Agreement with Novartis to Develop Novel Covalent Drug Candidate
5/15/09
Avila Therapeutics Appoints Katrine S. Bosley as Company
Atlas Venture, Ltd.,Polaris Venture Partners,Undisclosed Firm